Navigation Links
New guidelines for reproductive & developmental toxicity testing of oligonucleotide drugs
Date:10/30/2014

New Rochelle, NY, October 30, 2014—Oligonucleotide-based therapeutics present unique challenges when it comes to testing their potential to cause reproductive and developmental harm. New consensus guidelines for toxicity testing that take into consideration the combined chemical and biological characteristics of these novel biopharmaceuticals are presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers. The article is available free on the Nucleic Acid Therapeutics website until November 30, 2014.

Joy Cavagnaro, Access BIO (Boyce, VA), Cindy Berman, Berman Consulting (Wayland, MA), Doug Kornbrust, Preclinisight (Reno, NV), Tacey White, Exponent (Philadelphia, PA), Sarah Campion, Pfizer (Groton, CT), and Scott Henry, Isis Pharmaceuticals (Carlsbad, CA), coauthored the white paper that highlights key points to consider in the design of scientifically valid and predictive toxicity studies. The authors summarize the findings of the Reproductive Subcommittee of the Oligonucleotide Safety Working Group (OSWG) in the article "Considerations for Assessment of Reproductive and Developmental Toxicity of Oligonucleotide-Based Therapeutics."

"I highly commend this latest white paper from the OSWG to researchers and regulators alike involved in the development and implementation of oligonucleotide or antisense based interventions," says Executive Editor Graham C. Parker, PhD, The Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Children's Hospital of Michigan, Detroit, MI.

Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC, and C.A. Stein, MD, PhD, City of Hope National Medical Center, Duarte, CA; and Executive Editor Graham C. Parker, PhD.


'/>"/>

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
@LiebertOnline
Source:Eurekalert  

Related biology news :

1. UT Southwestern expert co-chairs national team to develop first comprehensive guidelines for management of sickle cell disease
2. Nineteen Tomato varieties evaluated under organic guidelines
3. Guidelines needed for creating germ cells in vitro, Cornell, JAX scientists state
4. Current guidelines underestimate US cervical cancer incidence and older womens risk
5. New patenting guidelines are needed for biotechnology
6. One size does not fit all: Dietary guidelines for choline may be insufficient
7. Nutrition guidelines needed for full-service restaurant chains
8. EASL publishes revised clinical practice guidelines to optimise the management of hepatitis C virus
9. Colon cancer screening guidelines may miss 10 percent of colon cancers
10. Weatherization work guidelines launched
11. Medboxs Marijuana Dispensing System Assists Operators in Complying with Federal Governments New Canna-Business Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New guidelines for reproductive & developmental toxicity testing of oligonucleotide drugs
(Date:2/6/2019)... ... February 04, 2019 , ... uBiome, the leader ... insights to help individuals understand how the gut microbes may increase the risk ... individuals eat foods that contain choline and L-carnitine, such as red meat and ...
(Date:2/2/2019)... ... January 31, 2019 , ... ... organization headquartered in Morrisville, NC, providing full, customizable clinical research services across ... to support educational programs for early stage life science entrepreneurs in the ...
(Date:1/25/2019)... ... January 24, 2019 , ... GrowthZone, Inc., provider ... The report indicates membership growth in some sectors and decreasing membership among others. ... responses from over 500 association professionals across North America. , “This year’s ...
Breaking Biology News(10 mins):
(Date:1/15/2019)... ... January 15, 2019 , ... Personalized treatment plans may extend life expectancy for ... a new study published in the journal Radiology. , Kidney, or renal, tumors ... a surgical procedure in which the tumor and part of the kidney are removed. ...
(Date:1/11/2019)... ... January 11, 2019 , ... Drawing on over 22 years of software ... at 2:30pm EST will explore some of the key lessons that have driven customer ... vs. using multiple vendors, and find out how to ensure that you continue to ...
(Date:1/10/2019)... ... 2019 , ... VGI Medical was founded in 2007 based on an invention ... the market including VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc and CerLoc systems are ... dual geometric design to limit motion of the affected spinal segment. Applying the principles ...
(Date:1/7/2019)... , ... January 07, 2019 , ... ... clinical trials of its Parkinson's Disease drug candidate, code-named "KM-819." KM-819 is ... Disease. The trial took place in South Korea. , This Phase 1 ...
Breaking Biology Technology: